Cargando…
Discovery, Function, and Therapeutic Targeting of Siglec-8
Siglecs (sialic acid-binding immunoglobulin-like lectins) are single-pass cell surface receptors that have inhibitory activities on immune cells. Among these, Siglec-8 is a CD33-related family member selectively expressed on human mast cells and eosinophils, and at low levels on basophils. These cel...
Autores principales: | Youngblood, Bradford A., Leung, John, Falahati, Rustom, Williams, Jason, Schanin, Julia, Brock, Emily C., Singh, Bhupinder, Chang, Alan T., O’Sullivan, Jeremy A., Schleimer, Robert P., Tomasevic, Nenad, Bebbington, Christopher R., Bochner, Bruce S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823959/ https://www.ncbi.nlm.nih.gov/pubmed/33374255 http://dx.doi.org/10.3390/cells10010019 |
Ejemplares similares
-
A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation
por: Schanin, Julia, et al.
Publicado: (2020) -
Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody
por: Gebremeskel, Simon, et al.
Publicado: (2021) -
Discovery of an agonistic Siglec-6 antibody that inhibits and reduces human mast cells
por: Schanin, Julia, et al.
Publicado: (2022) -
Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells
por: Robida, Piper A., et al.
Publicado: (2022) -
The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation
por: Korver, Wouter, et al.
Publicado: (2022)